I'm not sure that follows... based on TFA itself: > Academic labs aren’t waiting for the patent claims to get sorted out. Instead, they are racing to assemble

I'm not sure that follows... based on TFA itself: > Academic labs aren’t waiting for the patent claims to get sorted out. Instead, they are racing to assemble very large engineering teams to perfect and improve the genome-editing technique. On the Boston campus of Harvard’s medical school, for instance, George Church, a specialist in genomics technology, says he now has 30 people in his lab working on it. See also Myriad and the BRCA patents. You'd think patents would be an impediment to adoption, but turns out if something is really valuable, people will use it regardless and fight (sometimes all the way to the Supreme Court!) to keep using it.